Top Markets
Coin of the day
BRIM Biotechnology, Inc. BRIM Biotechnology, Inc.

BRIM Biotechnology, Inc.

6885
Rang in aandelen #22414
BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing... BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing innovative regenerative therapies to address both ophthalmic and degenerative joint conditions. Leading its pipeline is BRM 421, a topical ophthalmic solution designed to treat moderate-to-severe dry eye syndrome, which has successfully completed a Phase 2 clinical trial in the United States. The company's development efforts also encompass BRM 423, currently in Phase 1 clinical trials for severe corneal damage; BRM 424, also in Phase 1, targeting neurotrophic keratitis; and BRM 521, which aims to alleviate and repair tissue damage caused by osteoarthritis. Founded in 2013, BRIM Biotechnology is headquartered in Taipei, Taiwan.
Aandeelprijs
$0.66936954
Laatst gesynchroniseerd: 2026-07-28
Marktkapitalisatie
$89.04M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-40.10%
Land
TW
Handel BRIM Biotechnology, Inc. (6885)

Categorie

Dividendrendementgeschiedenis voor BRIM Biotechnology, Inc. (6885)
Het dividendrendement (TTM) van BRIM Biotechnology, Inc. (aandelsymbool: 6885) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van BRIM Biotechnology, Inc. (6885) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH